IE 11 is a very old browser and is not supported on this site.

Outlook 2024

Management report

Galenica will continue to implement the initiatives formulated in the strategic programmes in a focused manner. This includes further linking and expanding the range of products and services across all sales channels.


Products & Care

  • The pharmacy network is being continuously optimised and expanded, including through investments in the store design and advisory concept at physical points of sale.
  • The online shops of the Galenica pharmacies are undergoing technical and qualitative improvements by gradually switching to a new technological platform and expanding the online offerings. The Galenica pharmacies’ loyalty programme is also being further developed.
  • The importance of the pharmacy as the first point of contact for health questions is to be developed further. To this end, customer access to advice and services will be further simplified and the service portfolio will be better adapted to customer needs. In addition, Galenica is committed to ensuring that the advice and services provided in pharmacies are reimbursed by other health insurance providers within the scope of supplementary insurance.
  • In order to increase employee motivation and counteract the shortage of qualified employees, the roles of pharmacy assistants are starting to incorporate additional competencies and responsibilities in pharmacies. Targeted development opportunities are also to be created for this purpose.
  • In the home care and care home sector, the cooperation between Bichsel, Mediservice, Medifilm, Lifestage Solutions and Emeda will be further expanded so that customers can fully benefit from the added value and new offers. The aim is to attract more customers. In addition, the applications and platforms established with customers will be bundled into a central digital platform.
  • As of January 2024, Galenica acquired a 33% stake in Farmadomo Home Care Provider SA, the leading home care organisation in the field of clinical nutrition and blister packaging of medicines in the canton of Ticino. Galenica is thus also significantly expanding its home care offerings in Ticino.

Logistics & IT

  • Following the successful pilot projects, the “electronic prescription” is to be implemented as a new standard for service providers. Galenica is also actively participating in the development of national standards.
  • The “Documedis®” software solution from HCI Solutions is to be introduced for more doctors, care homes and hospitals. The use of “Clinical Decision Support Checks” is also to be further promoted in the interests of greater patient safety.
  • At the Niederbipp site, Galexis is planning to expand capacity for B2B and B2C logistics.
  • The implementation of the defined measures for achieving the sustainability goals is also a top priority. For example, further pilot projects with alternative drive systems for delivery vehicles, such as hydrogen, are to be launched and the necessary charging infrastructure for company vehicles is to be set up at relevant locations.

Guidance 2024

Galenica expects sales growth of between 3% and 5% for the 2024 financial year. Galenica expects adjusted1 EBIT to increase by between 8% and 11%. Adjusted for the special factors in the 2023 financial year in the amount of CHF 9.8 million, this results in a stable development of the adjusted1 EBIT margin (ROS) at 5.4%. Galenica strives for strong yet sustainable dividend growth and plans a dividend for 2024 at least at the previous year’s level.

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer